Correspondence

Challenges in the gene therapy commercial ecosystem

  • Subscribe to Nature Biotechnology for full access:

    $2.5E+2

    Subscribe

Additional access options:

Already a subscriber?  Log in  now or  Register  for online access.

References

  1. 1.

    , & Nat. Rev. Genet. 4, 346–358 (2003).

  2. 2.

    , , & Nat. Biotechnol. 23, 1073–1078 (2005).

  3. 3.

    Hum. Gene Ther. 23, 1–3 (2012).

  4. 4.

    & Acad. Manage. J. 58, 1180–1207 (2015).

  5. 5.

    & Nat. Biotechnol. 32, 874–876 (2014).

Download references

Author information

Affiliations

  1. The Wharton School, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

    • Rahul Kapoor
  2. IESE Business School, Barcelona, Spain.

    • Thomas Klueter
  3. Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

    • James M Wilson

Authors

  1. Search for Rahul Kapoor in:

  2. Search for Thomas Klueter in:

  3. Search for James M Wilson in:

Competing interests

J.M.W. is an advisor to REGENXBIO, Dimension Therapeutics and Solid Gene Therapy, and is a founder of, holds equity in, and has a sponsored research agreement with REGENXBIO and Dimension Therapeutics. In addition, he is a consultant to several biopharmaceutical companies and is an inventor on patents licensed to various biopharmaceutical companies.

Corresponding author

Correspondence to Rahul Kapoor.